Back to Studies
P1061s / Evaluation of Immunologic Mememory in HIV-Infected Children Treated with HAART.
Evaluation of Immunologic Memory Following Pneumococcal, Hepatitis B, and Measles Vaccination in HIV-Infected Children Treated with Highly Active Antiretroviral Therapy (HAART)
Primary Protocol Team Members
P1061s was a follow-up substudy of P1024 study to evaluate the persistence of immunologic memory to pneumococcal conjugate vaccine (PCV) and pneumococcal polysaccharide vaccine (PPV), measles vaccine (MMR), and hepatitis B virus (HBV) vaccine in HIV-infected subjects on HAART who participated in, and completed, P1024. The study was designed to determine whether HIV-infected children have evidence of pneumococcal type-specific, hepatitis B-specific, and measles-specific immunologic memory 3-4 years after receiving the vaccines while on HAART.
Loading study documents...
Loading study sites...
Loading study protocol team...
Loading study press...
Loading study publications/presentations...